Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 139 publications
Effect of tango versus exercise on chemotherapy-induced neuropathy after breast cancer treatment: a Phase II randomized controlled trial.
Journal: Research square
Published: August 20, 2026
Erratum: VIKTORIA-1 Trial of Gedatolisib Plus Fulvestrant With or Without Palbociclib in Hormone Receptor-Positive/HER2-/PIK3CA Wild-Type Advanced Breast Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 04, 2026
The gut microbiome in chemotherapy-induced fatigue: Exploring clinical associations and modulation via fecal microbiota transplantation in female mice.
Journal: International immunopharmacology
Published: May 07, 2026
Denosumab as Second-Line Treatment in Patients With Metastatic Breast Cancer: A Retrospective Descriptive Pilot Study From a Single Institution.
Journal: Cancer control : journal of the Moffitt Cancer Center
Published: May 04, 2026
VIKTORIA-1 Trial of Gedatolisib Plus Fulvestrant With or Without Palbociclib in Hormone Receptor-Positive/HER2-/PIK3CA Wild-Type Advanced Breast Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 09, 2026
Management of bone metastases in patients with breast cancer: review of bone-modifying therapy, emerging new agents, and future directions.
Journal: Frontiers in oncology
Published: March 05, 2026
Primed to feel, not to flare: Early life adversity and psychological sensitivity to interleukin-6 in a randomized trial among middle-aged female breast cancer survivors.
Journal: Brain, behavior, and immunity
Published: December 31, 2025
Impact of Oncotype DX risk categorization and receipt of chemotherapy on survival outcomes among patients with small node-negative HR+ breast cancer.
Journal: The oncologist
Published: December 22, 2025
Case Report: Late choroidal metastasis from hormone receptor-positive, HER2-negative breast cancer responsive to first-line endocrine therapy.
Journal: Frontiers in oncology
Published: October 06, 2025
Chemotherapy-induced estradiol reduction is associated with less relief of pre-chemotherapy anxiety in breast cancer patients.
Journal: Psychoneuroendocrinology
Published: August 02, 2025
Safely Stopping Premedications in Patients Receiving Paclitaxel: A Randomized Trial.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: July 29, 2025
Gut microbiota and metabolite disruption during breast cancer chemotherapy is associated with peripheral neuropathy sensory symptoms and pain.
Journal: Brain, behavior, and immunity
Published: July 28, 2025
Last Updated: 09/26/2026